REVIEW article
Front. Pharmacol.
Sec. Ethnopharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1662839
This article is part of the Research TopicPhytochemical Interventions to CancerView all 8 articles
The Antitumor Potential of Polygonatum spp.: A Narrative Review of Traditional Uses, Bioactive Metabolites, and Multi-Targeted Mechanisms
Provisionally accepted
- Graduate School, Hunan University of Chinese Medicine, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Polygonatum spp., encompassing various species within the genus, is a traditional Chinese botanical drug. It is known for its pharmacological effects, including qi tonification, yin nourishment, spleen invigoration, lung moistening, and kidney tonification. Polygonatum contains abundant bioactive metabolites, such as polysaccharides, steroidal saponins, flavonoids, volatile metabolites, and alkaloids. Recent research primarily revolves around its anti-inflammatory, anti-ageing, and glycaemic regulatory properties, while its antitumor potential remains comparatively underexplored. Malignant tumors represent a considerable global public health obstacle and are now a leading contributor to the global disease burden. The identification of effective antitumor agents and therapeutic strategies is urgent. Bioactive metabolites in Polygonatum have shown strong cytotoxic and pro-apoptotic impacts in vitro and in vivo. However, current research mostly focuses on isolated metabolites, lacking comprehensive narrative analysis. This review endeavors to narratively summarize recent advances on the antitumor activity and underlying mechanisms of Polygonatum, critically evaluate existing research gaps, and proposes future directions to facilitate the development of Polygonatum as a potential novel anticancer agent.
Keywords: Polygonatum spp., Traditional uses, antitumor activity, Bioactive metabolites, Multi-targeted mechanisms, Pharmacologicalproperties
Received: 09 Jul 2025; Accepted: 22 Oct 2025.
Copyright: © 2025 Zhu, Chen, Li, Yi, Yuan, Liu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wenlong Liu, dragon5240@126.com
Xili Zhang, xiaoli610@126.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.